Patricia Laura Maran

Patricia Laura Maran

Auto-generated profile, based on publicly available information

Patricia Laura Maran

Psychiatry, Mental Health and Addictions Group, Vall d'Hebron Research Institute (VHIR), Instituto de Investigación Sanitaria Acreditado Instituto de Investigación - Hospital Universitario Vall d'Hebron (IR-HUVH), Barcelona, Catalonia, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2025 in JMIR Mental Health
Verified
Journal Article
Open access
PMPatricia Laura Maran
Patricia Laura Maran
María Dolores BraquehaisMaría Dolores Braquehais
María Dolores Braquehais
AVAlexandra Vlaic
Alexandra Vlaic
MAMaría Teresa Alonzo-Castillo
María Teresa Alonzo-Castillo
JVJúlia Vendrell-Serres
Júlia Vendrell-Serres
ARAmanda Rodriguez-Urrutia
Amanda Rodriguez-Urrutia
Background: Despite the high prevalence and significant burden of depression, underdiagnosis remains a persistent challenge. Automatic speech analysis (ASA) has emerged as a promising method for depression assessment. However, a comprehensive quantitative synthesis evaluating its diagnostic accuracy is still lacking. Objective: This systematic review and meta-analysis aimed to assess the diagnostic performance of ASA in detecting depression, considering both machine learning and deep learning approaches. Methods: We conducted a systematic search across 8 databases, including MEDLINE, PsycInfo, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar from January 2013 to April 1, 2025. We included studies published in English that evaluated the accuracy of ASA for detecting depression, and reported performance metrics such as accuracy, sensitivity, specificity, precision, or confusion matrices. Study quality was assessed using a modified version of the Quality Assessment of Studies of Diagnostic Accuracy-Revised. A 3-level meta-analysis was performed to estimate the pooled highest and lowest accuracy, sensitivity, specificity, and precision. Meta-regressions and subgroup analyses were performed to explore heterogeneity across various factors, including type of publication, artificial intelligence algorithms, speech features, speech-eliciting tasks, ground truth assessment, validation approach, dataset, dataset language, participants’ mean age, and sample size. Results: Of the 1345 records identified, 105 studies met the inclusion criteria. The pooled mean of the highest accuracy, sensitivity, specificity, and precision were 0.81 (95% CI 0.79 to 0.83), 0.84 (95% CI 0.81 to 0.86), 0.83 (95% CI 0.79 to 0.86), and 0.81 (95% CI 0.77 to 0.84), respectively, whereas the pooled mean of the lowest accuracy, sensitivity, specificity, and precision were 0.66 (95% CI 0.63 to 0.69), 0.63 (95% CI 0.58 to 0.68), 0.60 (95% CI 0.55 to 0.66), and 0.64 (95% CI 0.58 to 0.70), respectively. Conclusions: ASA shows promise as a method for detecting depression, though its readiness for clinical application as a standalone tool remains limited. At present, it should be regarded as a complementary method, with potential applications across diverse contexts. Further high-quality, peer-reviewed studies are needed to support the development of robust, generalizable models and to advance this emerging field. Trial Registration: PROSPERO CRD42023444431; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023444431

10 October 2023 in BJPsych Open
Verified
Journal Article
Open access
PDF file
PMPatricia Laura Maran
Patricia Laura Maran
SKSilvia S. Klokgieters
Silvia S. Klokgieters
EGErik J. Giltay
Erik J. Giltay
POPatricia van Oppen
Patricia van Oppen
FJFrederike Jörg
Frederike Jörg
AKAlmar A. L. Kok
Almar A. L. Kok
Background: Despite growing concerns about mental health during the COVID-19 pandemic, particularly in people with pre-existing mental health disorders, research has shown that symptoms of depression and anxiety were generally quite stable, with modest changes in certain subgroups. However, individual differences in cumulative exposure to COVID-19 stressors have not been yet considered. Aims: We aimed to quantify and investigate the impact of individual-level cumulative exposure to COVID-19-pandemic-related adversity on changes in depressive and anxiety symptoms and loneliness. In addition, we examined whether the impact differed among individuals with various levels of pre-pandemic chronicity of mental health disorders. Method: Between April 2020 and July 2021, 15 successive online questionnaires were distributed among three psychiatric case–control cohorts that started in the 2000s (N = 1377). Outcomes included depressive and anxiety symptoms and loneliness. We developed a COVID-19 Adversity Index (CAI) summarising up to 15 repeated measures of COVID-19-pandemic-related exposures (e.g. exposure to COVID-19 infection, negative economic impact and quarantine). We used linear mixed linear models to estimate the effects of COVID-19-related adversity on mental health and its interaction with pre-pandemic chronicity of mental health disorders and CAI. Results: Higher CAI scores were positively associated with higher increases in depressive symptoms, anxiety symptoms and loneliness. Associations were not statistically significantly different between groups with and without (chronic) pre-pandemic mental health disorders. Conclusions: Individual differences in cumulative exposure to COVID-19-pandemic-related adversity are important predictors of mental health, but we found no evidence for higher vulnerability among people with (chronic) pre-pandemic mental health disorders.

15 October 2025 in Intelligence-Based Medicine
Verified
Journal Article
Open access
PGPeru Gabirondo
Peru Gabirondo
MGMaría García-Martínez
María García-Martínez
APAna Pozueta-Cantudo
Ana Pozueta-Cantudo
PMPatricia Laura Maran
Patricia Laura Maran
PDPatricia Dias
Patricia Dias
EREloy Rodriguez-Rodriguez
Eloy Rodriguez-Rodriguez

29 December 2025 in JMIR Preprints
Verified
Preprint
Open access
PMPatricia Laura Maran
Patricia Laura Maran
PGPeru Gabirondo
Peru Gabirondo
AVAlexandra Vlaic
Alexandra Vlaic
MAMaria Teresa Alonzo-Castillo
Maria Teresa Alonzo-Castillo
TRTomas Rojo
Tomas Rojo
ARAmanda Rodríguez-Urrutia
Amanda Rodríguez-Urrutia
BACKGROUND While most research on automatic speech analysis (ASA) has focused on acoustic features, the potential of linguistic markers remains underexplored, particularly in clinically diagnosed, non-English-speaking populations. OBJECTIVE This study evaluated the integration of acoustic and linguistic markers for detecting depression in a Spanish-speaking clinical sample. METHODS The sample included 80 patients with major depressive disorder (MDD) or persistent depressive disorder (PDD) from the Psychiatry Department of Vall d'Hebron University Hospital and 71 healthy controls. Participants answered 11 open-ended questions related to depressive symptoms and well-being via a web-based platform. Linguistic and acoustic variables spanning four categories, namely, prosodic, cepstral, spectral, and Teager Energy Operator (TEO)-based features, were extracted. Group comparisons and logistic regressions were performed to assess the predictive value of acoustic and linguistic features. Machine learning models were used to compare the performance of acoustic, linguistic, and ensemble classification models combining both feature sets. RESULTS TEO-based and cepstral features showed the strongest predictive power. Among linguistic features, greater use of verbs, reduced use of nouns and past-tense verbs, smaller vocabulary size, and increased use of shorter words and sentences remained strong predictors of depression after adjusting for covariates. The linguistic model outperformed the acoustic model (AUC = 0.86 vs. = 0.79), while the ensemble model combining both acoustic and linguistic features achieved comparable overall performance (AUC = 0.86), with slightly improved accuracy (0.84) and specificity (0.93). CONCLUSIONS Linguistic features differentiated patients with depression from healthy controls. With further validation and refinement, brief speech-based assessments could aid early depression detection in primary care and community settings.

23 October 2024 in JMIR Preprints
Verified
Preprint
Open access
PMPatricia Laura Maran
Patricia Laura Maran
María Dolores BraquehaisMaría Dolores Braquehais
María Dolores Braquehais
AVAlexandra Vlaic
Alexandra Vlaic
MAMaría Teresa Alonzo-Castillo
María Teresa Alonzo-Castillo
JVJúlia Vendrell-Serres
Júlia Vendrell-Serres
ARAmanda Rodriguez-Urrutia
Amanda Rodriguez-Urrutia
BACKGROUND Despite the high prevalence and significant burden of depression, underdiagnosis remains a persistent challenge. Automatic speech analysis (ASA) has emerged as a promising method for depression assessment. However, a comprehensive quantitative synthesis evaluating its diagnostic accuracy is still lacking. OBJECTIVE This systematic review and meta-analysis aimed to assess the diagnostic performance of ASA in detecting depression, considering both machine learning and deep learning approaches. METHODS We conducted a systematic search across 8 databases, including MEDLINE, PsycInfo, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar from January 2013 to April 1, 2025. We included studies published in English that evaluated the accuracy of ASA for detecting depression, and reported performance metrics such as accuracy, sensitivity, specificity, precision, or confusion matrices. Study quality was assessed using a modified version of the Quality Assessment of Studies of Diagnostic Accuracy-Revised. A 3-level meta-analysis was performed to estimate the pooled highest and lowest accuracy, sensitivity, specificity, and precision. Meta-regressions and subgroup analyses were performed to explore heterogeneity across various factors, including type of publication, artificial intelligence algorithms, speech features, speech-eliciting tasks, ground truth assessment, validation approach, dataset, dataset language, participants’ mean age, and sample size. RESULTS Of the 1345 records identified, 105 studies met the inclusion criteria. The pooled mean of the highest accuracy, sensitivity, specificity, and precision were 0.81 (95% CI 0.79 to 0.83), 0.84 (95% CI 0.81 to 0.86), 0.83 (95% CI 0.79 to 0.86), and 0.81 (95% CI 0.77 to 0.84), respectively, whereas the pooled mean of the lowest accuracy, sensitivity, specificity, and precision were 0.66 (95% CI 0.63 to 0.69), 0.63 (95% CI 0.58 to 0.68), 0.60 (95% CI 0.55 to 0.66), and 0.64 (95% CI 0.58 to 0.70), respectively. CONCLUSIONS ASA shows promise as a method for detecting depression, though its readiness for clinical application as a standalone tool remains limited. At present, it should be regarded as a complementary method, with potential applications across diverse contexts. Further high-quality, peer-reviewed studies are needed to support the development of robust, generalizable models and to advance this emerging field. CLINICALTRIAL PROSPERO CRD42023444431; https://www.crd.york.ac.uk/PROSPERO/view/CRD42023444431